At the end of the inspection, no Form 483 was issued by the USFDA ... during March 10-14. The US FDA closed the inspection with zero observations. This is the second consecutive zero 483 ...

Alkem Laboratories: The US FDA did not issue a form 483 following the bioresearch monitoring inspection at the bioequivalence centre in Maharashtra. GR Infraprojects: The company has emerged as the ...

Shilpa Medicare Shilpa Medicare’s subsidiary, Shilpa Pharma Lifesciences, underwent an inspection by the US FDA at its Raichur-based Unit-2 facility. The inspection resulted in a Form 483 with zero ...

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Court 14, First Floor 210 William Street, Melb. Ronphos Corporation (ARBN 117 022 483) v. Mideo Jia Pty Ltd (ACN 605 094 808) Court 15, Ground Floor 210 William Street, Melb. Margaret Bottomley v.

WAUSAU, Wis (WAOW) -- The Great Dane has announced they'll be closing the doors of their Wausau location after 15 years. In a Facebook post Thursday morning, the company said food costs and ...